Virtus Investment Advisers, LLC

Position in CYTK — Cytokinetics Inc

CIK 19481 HARTFORD, CT

Position in CYTK

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,412,194

+$1,128,584 QoQ

Shares Held

16,577

+285.2% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#242

of 477 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Virtus Investment Advisers, LLC holds $130,556,170 across 185 Biotechnology names. CYTK ranks #12 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	29,544	$3,349,107
2	ALNY	Alnylam Pharmaceuticals, Inc.	9,953	$2,996,151
3	REGN	Regeneron Pharmaceuticals, Inc.	4,320	$2,693,692
4	MRNA	Moderna, Inc.	23,300	$1,631,699
5	RARE	Ultragenyx Pharmaceutical Inc.	47,757	$1,594,606
6	PGEN	Precigen, Inc.	261,322	$1,489,535
7	AGIO	Agios Pharmaceuticals, Inc.	39,473	$1,464,843
8	RYTM	Rhythm Pharmaceuticals, Inc.	13,158	$1,460,932

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,412,194	16,577	+285.2%	Shares	Other	2026-08-11
2026-03-31	$283,610	4,303	+1.3%	Shares	Other	2026-05-14
2025-12-31	$269,854	4,247	+23.9%	Shares	Other	2026-02-17
2025-09-30	$188,402	3,428	+21.0%	Shares	Other	2025-11-14
2025-06-30	$93,569	2,832	-13.4%	Shares	Other	2025-08-13
2025-03-31	$131,421	3,270	-30.7%	Shares	Other	2025-05-15
2023-12-31	$393,905	4,718	-45.5%	Shares	Other	2024-02-15
2023-09-30	$255,241	8,664	+9.1%	Shares	Other	2023-11-08
2023-06-30	$259,133	7,944	-38.0%	Shares	Other	2023-08-14
2023-03-31	$450,924	12,814	-12.1%	Shares	Other	2023-05-15
2022-12-31	$668,101	14,581	0.0%	Shares	Other	2023-02-14
2022-09-30	$706,449	14,581	—	Shares	Other	2022-11-14
No filing history on record for this holder in this stock.